Berg, a small Boston-based biotech firm, teams up with a group of hospitals and research teams to discover and treat pancreatic cancer by means of a clinical biomarker.
Pancreatic cancer is one of the deadliest forms of the disease, with an average five-year survival rate. Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital and the Pancreatic Cancer Research Team (PCRT), will join hands to find a biomarker for pancreatic cancer.
Pancreatic Cancer
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
Advertisement
Finding a cure for pancreatic cancer and other aggressive types of cancers in not the priority of most well established pharmaceutical companies. Instead, large pharmaceutical companies tend to focus their research and development dollars on rare diseases, where profit margins are extremely high and finding a cure for cancer is really tough.
Berg's first drug, BPM 31510, reprograms the metabolism of the cancer cells, re-teaching them to undergo apoptosis, or cell death. The cancer cells die off naturally, without the need for harmful and expensive chemotherapy.
The company has plans to use data and artificial intelligence algorithms, to isolate the root causes of many diseases, including cancer, and develop tailor-made treatment options for patients.
Source: Medindia
The company has plans to use data and artificial intelligence algorithms, to isolate the root causes of many diseases, including cancer, and develop tailor-made treatment options for patients.
Source: Medindia
Early Detection Beneficial When Pancreatic Cancer Runs in the Family
Pancreatic cancer is a deadly form of cancer with a very high mortality rate. New research shows that early detection of pancreatic cancer offers a better chance of long-term survival.
Advertisement
 | Advertisement
|
New Method That Lets an Earlier Diagnosis of Pancreatic Cancer Developed
Researchers have devised a new method than allows an earlier diagnosis of pancreatic cancer.
Advertisement
Recommended Reading
Latest Cancer News
Comprehending the association between the gut microbiome and polyp growth sheds insights into potential screenings and treatments.
The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Colon cancer's hidden link revealed in microbiome study.